483 Beijing Rimeng Biological Technology Oct 2017

483 Beijing Rimeng Biological Technology Oct 2017

Meisha Sampson FDA$119.00 - Available Now

FDA investigators audited the Beijing Rimeng Biological Technology - Beijing, China facility and issued inspectional observations (via FDA 483) on 11 Oct 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 11 Oct 2017
  • Location: Beijing, China
  • FEI: 3005660579
Add To Cart